valdecoxib has been researched along with Glaucoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, T; Gao, Z; He, Y; Huang, J; Huang, Y; Li, M; Meng, J; Saro, A; Xia, X; Yao, F | 1 |
1 other study(ies) available for valdecoxib and Glaucoma
| Article | Year |
|---|---|
Valdecoxib Protects against Cell Apoptosis Induced by Endoplasmic Reticulum Stress via the Inhibition of PERK-ATF4-CHOP Pathway in Experimental Glaucoma.
Topics: Activating Transcription Factor 4; Animals; bcl-2-Associated X Protein; Caspase 3; eIF-2 Kinase; Endoplasmic Reticulum Stress; Glaucoma; Glucose; Oxygen; Rats; Rats, Sprague-Dawley; Signal Transduction; Transcription Factor CHOP | 2022 |